Acceptability of Human Papillomavirus (HPV) Self-sampling Tools for Cervical Cancer Prevention
Acceptability of HPV Self-sampling Tools for Cervical Cancer Prevention in Jamaican Women: A Theory-based Approach to Culturally-tailored Message Design
Sponsor: University of Miami
Terminated
Budgetary and Timing Constraints
Other terminated trials from University of Miami
Other Cervical Cancer trials with similar outcome
Listed as NCT03613493, this NA trial focuses on Cervical Cancer and remains terminated or withdrawn. Sponsored by University of Miami, it has been updated 9 times since 2018, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2023 — Jul 2024 [monthly]
Terminated NA
-
Dec 2022 — Jan 2023 [monthly]
Terminated NA
-
Jan 2021 — Dec 2022 [monthly]
Terminated NA
▶ Show 4 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Terminated NA
-
Sep 2019 — Feb 2020 [monthly]
Terminated NA
Status: Completed → Terminated
-
Jan 2019 — Sep 2019 [monthly]
Completed NA
Status: Recruiting → Completed
-
Sep 2018 — Jan 2019 [monthly]
Recruiting NA
First recorded
Jul 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Miami
For direct contact, visit the study record on ClinicalTrials.gov .